Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet Sells 5,318 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Myriam Curet sold 5,318 shares of the firm’s stock in a transaction dated Tuesday, April 23rd. The stock was sold at an average price of $370.66, for a total value of $1,971,169.88. Following the completion of the transaction, the executive vice president now directly owns 298 shares in the company, valued at $110,456.68. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Myriam Curet also recently made the following trade(s):

• On Friday, March 1st, Myriam Curet sold 1,605 shares of Intuitive Surgical stock. The stock was sold at an average price of $383.48, for a total value of $615,485.40.
• On Monday, February 12th, Myriam Curet sold 481 shares of Intuitive Surgical stock. The stock was sold at an average price of $386.09, for a total value of $185,709.29.
• On Friday, January 26th, Myriam Curet sold 4,318 shares of Intuitive Surgical stock. The stock was sold at an average price of $370.15, for a total value of $1,598,307.70.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $375.01 on Thursday. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The stock’s 50 day simple moving average is $386.40 and its two-hundred day simple moving average is $345.19. The company has a market cap of $133.02 billion, a price-to-earnings ratio of 67.69, a PEG ratio of 4.83 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The business had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same quarter in the previous year, the company posted $1.00 EPS. The company’s revenue was up 11.5% compared to the same quarter last year. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 4.84 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently weighed in on ISRG. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Jefferies Financial Group lifted their price objective on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a research report on Friday, April 19th. Raymond James lifted their price objective on Intuitive Surgical from $372.00 to $435.00 and gave the company an “outperform” rating in a research report on Thursday, January 25th. Truist Financial lifted their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Finally, Barclays lifted their price objective on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a research report on Thursday, January 25th. Five investment analysts have rated the stock with a hold rating and thirteen have given a buy rating to the stock. According to MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $396.17.

Institutional Trading of Intuitive Surgical

A number of large investors have recently added to or reduced their stakes in ISRG. Vanguard Group Inc. increased its position in shares of Intuitive Surgical by 0.7% during the 3rd quarter. Vanguard Group Inc. now owns 29,868,227 shares of the medical equipment provider’s stock valued at $8,730,184,000 after purchasing an additional 196,316 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Intuitive Surgical by 1.6% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 16,973,266 shares of the medical equipment provider’s stock valued at $5,726,102,000 after purchasing an additional 272,741 shares during the last quarter. Edgewood Management LLC increased its position in shares of Intuitive Surgical by 7.9% during the 4th quarter. Edgewood Management LLC now owns 5,131,066 shares of the medical equipment provider’s stock valued at $1,731,016,000 after purchasing an additional 374,667 shares during the last quarter. Jennison Associates LLC increased its position in shares of Intuitive Surgical by 6.4% during the 3rd quarter. Jennison Associates LLC now owns 4,585,190 shares of the medical equipment provider’s stock valued at $1,340,205,000 after purchasing an additional 274,692 shares during the last quarter. Finally, Fisher Asset Management LLC increased its position in shares of Intuitive Surgical by 2.0% during the 4th quarter. Fisher Asset Management LLC now owns 4,494,373 shares of the medical equipment provider’s stock valued at $1,516,222,000 after purchasing an additional 88,977 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.